Results 11 to 20 of about 100,585 (295)
A review on Acinetobacter baumannii
Acinetobacter baumannii is a major cause of nosocomial infections worldwide. By summarizing the epidemiology, molecular and drug resistance mechanisms, diagnosis and treatment strategies of Acinetobacter baumannii, the clinical outcome is finally ...
Xin Wang, Li-Jie Qin
doaj +3 more sources
Acinetobacter baumannii is a ubiquitous, Gram-negative, nonflagellated coccobacillus bacterium commonly isolated from the environment. In human medicine, this opportunistic pathogen is responsible for hospital- and community-acquired infections. Resistance to last-resort antibiotics, such as colistin, tigecycline, and carbapenems, earns this bacterium ...
Clémence Whiteway+3 more
openaire +3 more sources
The response to desiccation in <i>Acinetobacter baumannii</i>. [PDF]
The long-term resistance to desiccation on abiotic surfaces is a key determinant of the adaptive success of Acinetobacter baumannii as a healthcare-associated bacterial pathogen. Here, the cellular and molecular mechanisms enabling A. baumannii to resist desiccation and persist on abiotic surfaces were investigated. Experiments were set up to mimic the
Lucidi M+12 more
europepmc +5 more sources
Tackling Acinetobacter baumannii
Globally, multidrug-resistant (MDR) bacteria represent a menace to public health [...]
Guido Granata+2 more
openaire +2 more sources
Glycosphingolipids Recognized by Acinetobacter baumannii [PDF]
Acinetobacter baumannii is an opportunistic bacterial pathogen associated with hospital-acquired infections, including pneumonia, meningitis, bacteremia, urinary tract infection, and wound infections. Recognition of host cell surface carbohydrates plays a crucial role in adhesion and enables microbes to colonize different host niches.
Miralda Madar Johansson+6 more
openaire +4 more sources
Subunit vaccines for Acinetobacter baumannii
Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen in hospitals. A. baumannii infection has become a challenging problem in clinical practice due to the increasing number of multidrug-resistant strains and their prevalence worldwide. Vaccines are effective tools to prevent and control A. baumannii infection.
Ning Yang+6 more
openaire +3 more sources
Acinetobacter in veterinary medicine, with an emphasis on Acinetobacter baumannii [PDF]
Acinetobacter spp. are aerobic, rod-shaped, Gram-negative bacteria belonging to the Moraxellaceae family of the class Gammaproteobacteria and are considered ubiquitous organisms. Among them, Acinetobacter baumannii is the most clinically significant species with an extraordinary ability to accumulate antimicrobial resistance and to survive in the ...
J.H. van der Kolk+4 more
openaire +4 more sources
Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospital-acquired infections. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrug-resistant (MDR) strains, has significantly raised the ...
Michael O’Donoghue+3 more
openaire +3 more sources
Iron and Acinetobacter baumannii Biofilm Formation [PDF]
Acinetobacter baumannii is an emerging nosocomial pathogen, responsible for infection outbreaks worldwide. The pathogenicity of this bacterium is mainly due to its multidrug-resistance and ability to form biofilm on abiotic surfaces, which facilitate long-term persistence in the hospital setting. Given the crucial role of iron in A.
Gentile V+5 more
openaire +4 more sources
Structure and Evolution of Acinetobacter baumannii Plasmids [PDF]
Acinetobacter baumannii is an emergent bacterial pathogen that provokes many types of infections in hospitals around the world. The genome of this organism consists of a chromosome and plasmids. These plasmids vary over a wide size range and many of them have been linked to the acquisition of antibiotic-resistance genes.
Santiago Castillo-Ramírez+9 more
openaire +4 more sources